InvestorsHub Logo
Followers 52
Posts 5451
Boards Moderated 0
Alias Born 07/03/2020

Re: Gator328 post# 400964

Wednesday, 02/01/2023 4:55:44 PM

Wednesday, February 01, 2023 4:55:44 PM

Post# of 463633
If blarcamesine is disease modifying, it will be worth a whole lot more than if it's just a safe version of Lecanemab. Anavex would be able to sell to more patients, and charge more per patient -- and rightly so.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News